BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Gennao Bio, Juno Diagnostics Break Onto the Scene With Combined $65 Million

  The Series A rounds are the latest in a string of financing announcements made over the past few months.

  May 12, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  Going to Work Could be Safer than Staying Home in a Pandemic, U of Chicago Study Finds

  Staying at home during the COVID-19 pandemic actually increased the spread of infection, according to new study published by the University of Chicago and, soon, by the National Bureau of Economic Research.

  May 12, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Missing Emails Add Additional Layer to Sanofi’s Zantac Recall Drama

  Sanofi’s troubles stemming from the 2019 recall of Zantac appear to be far from over.

  May 12, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Genetown

  Decoding the Trends in COVID-19 Variants: Vaccines and Regions of Concern

  New mutations of the SARS-CoV-2 virus are continuing to be discovered. As we’ve seen from the most common variants of the virus, infectiousness appears to be the trait most familiar to all of them.

  May 12, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  New Cell Therapy Shows Promise in Treating HIV

  At the Seraph Research Institute, scientists presented new research at the 2021 ASGCT that shows promise in treating HIV.

  May 12, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Caris Life Sciences Closes Whopping $830 Million Growth Equity Round

  The company has raised approximately $1.3 billion in external financing over the past three years, including $310 million in 2020.

  May 12, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Biogen Options Stroke Asset from TMS Co. Following Positive Phase IIa Results

  Biogen is going all-in on a stroke drug it has been developing for the past three years in collaboration with Japan-based TMS Co.

  May 12, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Global Roundup: Shanghai Ecosystem Grows with Addition of Germany’s ITM AG

  Biopharma and life sciences from across the globe provide updates on their businesses and pipelines.

  May 12, 2021

   · 

  5 min read

   · 

  Alex Keown
• 

  Deals

  Money on the Move: May 5 - 11

  Catch up on the investment news quickly with BioSpace’s brief overview of the biotech companies hitting the Nasdaq and raking in fresh cash the past week.

  May 12, 2021

   · 

  7 min read

   · 

  Kate Goodwin
• 

  Business

  Two New Life Sciences VC Funds Established as Investment Appetite Grows

  Two new venture capital funds, Droia Ventures and Perceptive Advisors closed on new funds to invest in early-stage life science companies.

  May 12, 2021

   · 

  3 min read

   · 

  Mark Terry